Literature DB >> 19502106

Interactions of thioflavin T with serum albumins: spectroscopic analyses.

Priyankar Sen1, Sadaf Fatima, Basir Ahmad, Rizwan Hasan Khan.   

Abstract

The interaction of thioflavin T (ThT) with serum albumins from four different mammalian species i.e. human, bovine, porcine and rabbit, has been investigated by circular dichroism (CD), fluorescence spectroscopy and ITC. The binding constant (K) for HSA was found to be 9.9 x 10(4)M(-1), 4.3 x 10(4)M(-1) for RSA, 1.07 x 10(4)M(-1) for PSA and 0.3 x 10(4)M(-1) for BSA and the number of binding sites (n) were 1.14, 1.06, 0.94 and 0.8, respectively, which is very significant. By using unfolding pathway of HSA in the presence of urea, domain II of HSA has been assigned to possess binding site of ThT. Its binding constant is comparable to many drugs that bind at domain II of HSA, like salicylate, warfarin, digitoxin, etc. Acting force between HSA and ThT is showing that both hydrophobic and electrostatic forces have contributed for the interaction. DeltaG(binding), DeltaH and DeltaS were calculated to be -28.46 kJ mol(-1), -3.50 kJ mol(-1) and 81.04 JK(-1)mol(-1), respectively. The data described here will help to increase our understanding about the interaction of ThT with native proteins. The results also indicate that care must be taken while using ThT as a probe for detecting amyloid fibrils.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19502106     DOI: 10.1016/j.saa.2009.05.010

Source DB:  PubMed          Journal:  Spectrochim Acta A Mol Biomol Spectrosc        ISSN: 1386-1425            Impact factor:   4.098


  17 in total

1.  Human serum albumin inhibits Abeta fibrillization through a "monomer-competitor" mechanism.

Authors:  Julijana Milojevic; Annie Raditsis; Giuseppe Melacini
Journal:  Biophys J       Date:  2009-11-04       Impact factor: 4.033

Review 2.  Molecular and Clinical Aspects of Protein Aggregation Assays in Neurodegenerative Diseases.

Authors:  Anna Villar-Piqué; Matthias Schmitz; Niccolò Candelise; Salvador Ventura; Franc Llorens; Inga Zerr
Journal:  Mol Neurobiol       Date:  2018-02-10       Impact factor: 5.590

Review 3.  Insulin Formulation Characterization-the Thioflavin T Assays.

Authors:  Morten Schlein
Journal:  AAPS J       Date:  2016-12-20       Impact factor: 4.009

4.  Serum and Urine Thioflavin-T-Enhanced Fluorescence in Severe Preeclampsia.

Authors:  Katherine R Millen; Catalin S Buhimschi; Guomao Zhao; Kara M Rood; Sammy Tabbah; Irina A Buhimschi
Journal:  Hypertension       Date:  2018-04-23       Impact factor: 10.190

Review 5.  Molecular mechanism of Thioflavin-T binding to amyloid fibrils.

Authors:  Matthew Biancalana; Shohei Koide
Journal:  Biochim Biophys Acta       Date:  2010-04-22

6.  Inter-domain helix h10DOMI-h1DOMII is important in the molecular interaction of bovine serum albumin with curcumin: spectroscopic and computational analysis.

Authors:  Dhakaram Pangeni; Charu Kapil; Mohamad Aman Jairajpuri; Priyankar Sen
Journal:  Eur Biophys J       Date:  2015-02-05       Impact factor: 1.733

7.  Reevaluation of ANS binding to human and bovine serum albumins: key role of equilibrium microdialysis in ligand - receptor binding characterization.

Authors:  Irina M Kuznetsova; Anna I Sulatskaya; Olga I Povarova; Konstantin K Turoverov
Journal:  PLoS One       Date:  2012-07-19       Impact factor: 3.240

8.  Analyzing thioflavin T binding to amyloid fibrils by an equilibrium microdialysis-based technique.

Authors:  Irina M Kuznetsova; Anna I Sulatskaya; Vladimir N Uversky; Konstantin K Turoverov
Journal:  PLoS One       Date:  2012-02-24       Impact factor: 3.240

9.  Elucidating the influence of gold nanoparticles on the binding of salvianolic acid B and rosmarinic acid to bovine serum albumin.

Authors:  Xin Peng; Wei Qi; Renliang Huang; Rongxin Su; Zhimin He
Journal:  PLoS One       Date:  2015-04-10       Impact factor: 3.240

10.  Fluorescent filter-trap assay for amyloid fibril formation kinetics in complex solutions.

Authors:  Irem Nasir; Sara Linse; Celia Cabaleiro-Lago
Journal:  ACS Chem Neurosci       Date:  2015-05-20       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.